K-pop

TXT's Solo Album Debuts at No. 16 on the U.S. Billboard 200

Features six tracks, including the title track “Ice Cream” Best-Selling Album Among Solo Korean Artists Released This Year

KIM HYUNSIK
2026-07-22 10:14:18
[Edaily Starin KIM HYUNSIK Reporter] Yeonjun, a member of the boy group Tomorrow X Together (TXT), has made it onto the Billboard 200, the main U.S. album chart, with his solo album.
(Photo courtesy of Big Hit Music)
According to his agency, Big Hit Music, on the 22nd, Yeonjun’s second mini-album, “NO LABELS: PART 02,” ranked 16th on the latest Billboard 200 chart (dated July 25). This marks the highest ranking achieved by a Korean solo artist’s album released this year.
Following his first solo album released last year, Yeonjun demonstrated his strength by placing his new solo work on the Billboard 200. “NO LABELS: PART 02” took the No. 1 spot on the World Albums chart and ranked No. 4 on the Top Album Sales chart.
The album’s title track, “Ice Cream,” reached No. 89 on the Global (Excluding the U.S.) chart. Meanwhile, Yeonjun ranked 17th on the Artist 100 chart, which ranks artists.
“No Labels: Part 02” is an album consisting of six tracks in total, including “Ice Cream.” Yeonjun also included “Baby Wassup?” and “Long Way Long Ride,” songs for which he contributed to the lyrics, on the album.
Following the release of his new album, Yeonjun took first place on KBS 2TV’s “Music Bank” and MBC’s “Show! Music Core” with “Ice Cream.” He is scheduled to appear on Mnet’s “M Countdown” on the 23rd.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02